They're man's best friend and a part of the family, but their shorter lifespans mean most owners often have to say goodbye to their canine companions far too soon. However, that could soon change thanks to a biotech company working on a drug that . Loyal, the San Francisco biotech received confirmation Tuesday from the Food and Drug Administration for Veterinary Medicine that data on its candidate, LOY-001, supports 'reasonable expectations of effectiveness.'
Load More
Load More